Approval · Notice of Compliance 9871 · 2008
XAMIOL: Notice of Compliance 9871
Issued November 6, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9871
- Date
- November 6, 2008
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical antipsoriatic agent, vitamin d analogue, corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XAMIOL | 02319012 | Marketed |
Medicinal ingredients
- CALCIPOTRIOL MONOHYDRATE 50 MCG per G
- BETAMETHASONE DIPROPIONATE 0.5 MG per G